Showing results (1751-1760 of 4,541) with videos related to
Sort By:
Pageof 455
Journal of Gastroenterology|December 9, 2024
Standard technique in Japan for measuring hepatic venous pressure gradientYusuke Imai, Yohei Koizumi, Yoichi Hiasa, et al.Journal of Gastroenterology|December 9, 2024
Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptomsAkinari Sawada, Yoshimasa Hoshikawa, Hiroko Hosaka, et al.Journal of Gastroenterology|December 11, 2024
Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasionNaotaka Kugiyama, Katsuya Nagaoka, Rin Yamada, et al.Journal of Gastroenterology|November 20, 2024
Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLDHaili Wang, Zhenqiu Liu, Hong Fan, et al.Journal of Gastroenterology|November 18, 2024
YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathwayXiyu Wu, Kohei Yamashita, Chihiro Matsumoto, et al.Journal of Gastroenterology|November 16, 2024
Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide studyMuneji Yasuda, Masahiro Shiokawa, Takeshi Kuwada, et al.Journal of Gastroenterology|November 15, 2024
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatmentsYosuke Kasai, Takashi Ito, Toshihiko Masui, et al.Journal of Gastroenterology|September 21, 2024
Small extracellular vesicles derived from adipose mesenchymal stem cells alleviate intestinal fibrosis by inhibiting the FAK/Akt signaling pathway via MFGE8Zhizhong Xiong, Xianzhe Li, Minghao Xie, et al.Journal of Gastroenterology|September 19, 2024
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analysesKazuhiro Matsuyama, Shingo Yamada, Hironori Sato, et al.Journal of Gastroenterology|September 17, 2024
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective studyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.Pageof 455